Related references
Note: Only part of the references are listed.The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C
Caleb C. Lord et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Olanzapine and aripiprazole differentially affect glucose uptake and energy metabolism in human mononuclear blood cells
Britta Stapel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact
Chantel Kowalchuk et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity
Meng He et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Serotonin improves glucose metabolism by Serotonylation of the small GTPase Rab4 in L6 skeletal muscle cells
Ramona Al-Zoairy et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
Xuemei Liu et al.
SCIENTIFIC REPORTS (2017)
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
Stephen J. Cooper et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Association Study of GABAA α2 Receptor Subunit Gene Variants in Antipsychotic-Associated Weight Gain
Clement C. H. Zai et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Acute effects of oral olanzapine treatment on the expression of fatty acid and cholesterol metabolism-related gene in rats
Xuemei Liu et al.
LIFE SCIENCES (2015)
Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology
Leonel E. Rojo et al.
PHARMACOLOGICAL RESEARCH (2015)
Antipsychotics inhibit glucose transport: Determination of olanzapine binding site in Staphylococcus epidermidis glucose/H+ symporter
Petr Babkin et al.
FEBS OPEN BIO (2015)
Mitochondrial fragmentation impairs insulin-dependent glucose uptake by modulating Akt activity through mitochondrial Ca2+ uptake
Andrea del Campo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Insulin Stimulates Mitochondrial Fusion and Function in Cardiomyocytes via the Akt-mTOR-NF kappa B-Opa-1 Signaling Pathway
Valentina Parra et al.
DIABETES (2014)
Hypothalamic histamine HI receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats
Meng He et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Second Generation Antipsychotic-Induced Type 2 Diabetes: A Role for the Muscarinic M3 Receptor
Katrina Weston-Green et al.
CNS DRUGS (2013)
Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
Karen L. Teff et al.
DIABETES (2013)
Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1-deficient mice
F. Caffin et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
How insulin engages its primary binding site on the insulin receptor
John G. Menting et al.
NATURE (2013)
Olanzapine-Induced Hyperglycemia: Possible Involvement of Histaminergic, Dopaminergic and Adrenergic Functions in the Central Nervous System
Megumi Ikegami et al.
NEUROENDOCRINOLOGY (2013)
Clozapine-Induced Mitochondria Alterations and Inflammation in Brain and Insulin-Responsive Cells
Veronica Contreras-Shannon et al.
PLOS ONE (2013)
The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: Olanzapine monotherapy
Mehmet Ak et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways
V. Mondelli et al.
TRANSLATIONAL PSYCHIATRY (2013)
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study
Martien Wampers et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels
Katrina Weston-Green et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
Jee-Eun Oh et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
Katrina Weston-Green et al.
PLOS ONE (2012)
Atypical Antipsychotics Rapidly and Inappropriately Switch Peripheral Fuel Utilization to Lipids, Impairing Metabolic Flexibility in Rodents
Vance L. Albaugh et al.
SCHIZOPHRENIA BULLETIN (2012)
Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009
Juan A. Gallego et al.
SCHIZOPHRENIA RESEARCH (2012)
A Role for Hypothalamic AMP-Activated Protein Kinase in the Mediation of Hyperphagia and Weight Gain Induced by Chronic Treatment with Olanzapine in Female Rats
Ei Sejima et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis
V. L. Albaugh et al.
MOLECULAR PSYCHIATRY (2011)
Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation
Johan Ferno et al.
PLOS ONE (2011)
Body Mass Index Increase, Serum Leptin, Adiponectin, Neuropeptide Y and Lipid Levels during Treatment with Olanzapine and Haloperidol
N. R. B. Raposo et al.
PHARMACOPSYCHIATRY (2011)
Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism
Andrea L. Sertie et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Mitochondrial Dynamics: a Potential New Therapeutic Target for Heart Failure
Jovan Kuzmicic et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2011)
Antipsychotics and Schizophrenia: From Efficacy and Effectiveness to Clinical Decision-Making
George Foussias et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2010)
Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance
Paulo J. F. Martins et al.
DIABETES (2010)
Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study
Deanna L. Kelly et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Berberine Inhibits SREBP-1-related Clozapine and Risperidone induced Adipogenesis in 3T3-L1 Cells
Yueshan Hu et al.
PHYTOTHERAPY RESEARCH (2010)
Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-β
C. Pavan et al.
PHARMACOGENOMICS JOURNAL (2010)
Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes
Antonio Zorzano et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Weight effects associated with antipsychotics: A comprehensive database analysis
Bruce Parsons et al.
SCHIZOPHRENIA RESEARCH (2009)
Insulin resistance following continuous, chronic olanzapine treatment: An animal model
Araba F. Chintoh et al.
SCHIZOPHRENIA RESEARCH (2008)
The relationship between the response of clinical symptoms and plasma olanzapine concentration, based on pharmacogenetics
Motohiro Nozawa et al.
THERAPEUTIC DRUG MONITORING (2008)
No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation
F. M. Theisen et al.
PHARMACOGENOMICS JOURNAL (2007)
Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment
J. Minet-Ringuet et al.
MOLECULAR PSYCHIATRY (2007)
Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and antilipolysis
Helliner S. Vestri et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: Implications for adverse metabolic effects
Karen L. Houseknecht et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Mitochondria: More than just a powerhouse
Heidi M. McBride et al.
CURRENT BIOLOGY (2006)
Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells
J Engl et al.
MOLECULAR PSYCHIATRY (2005)
ZINC - A free database of commercially available compounds for virtual screening
JJ Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
Generating evidence to inform policy and practice: The example of the second generation atypical antipsychotics
J Geddes
SCHIZOPHRENIA BULLETIN (2003)
Studies on modulation of feeding behavior by atypical antipsychotics in female mice
G Kaur et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine
TD Ardizzone et al.
BRAIN RESEARCH (2001)
Share Paper
